OpenSAFELY
Reports

Vaccine Coverage - Third/Booster Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on THIRD/booster doses which are due, based on the booster dose schedule (6 months since second dose). * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
16 Nov 2021
Last updated
10 Jan 2022
DOI
http://doi.org/10.53764/rpt.e780b8d9d0
Links

OpenSAFELY COVID Vaccine coverage report: Booster / third doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our paper available here.

The full analytical methods behind the latest results in this report are available here.

Booster/Third doses

Report last updated 10 Jan 2022

Third dose vaccinations included up to 05 Jan 2022 inclusive

This report is intended to highlight any differences between subgroups of priority cohorts in receiving 'booster' doses (or third primary doses where eligible), at least 14 weeks after their second dose.

Only persons who had their second dose at least 14 weeks ago (29 Sep 2021) are included in the 'due' group.

Vaccine types

Note: numbers may not sum to 100% as it is not always possible to determine vaccine type given, and patients occasionally have more than one brand recorded on the same day.

Oxford-AZ vaccines (% of all third doses): 0.1% (13,391)

Pfizer vaccines (% of all third doses): 77.0% (9,171,820)

Moderna vaccines (% of all third doses): 22.9% (2,725,877)

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Cumulative third dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,039,528 45,024 994,504 95.7 1,089,634
Sex F 599,480 28,371 571,109 95.3 629,531
M 440,041 16,653 423,388 96.2 460,096
Age band 80-84 554,407 21,434 532,973 96.1 579,159
85-89 326,522 14,735 311,787 95.5 342,020
90+ 158,599 8,862 149,737 94.4 168,448
Ethnicity (broad categories) Black 8,246 1,428 6,818 82.7 10,913
Mixed 2,702 280 2,422 89.6 3,283
Other 5,523 532 4,991 90.4 6,727
South Asian 24,360 3,689 20,671 84.9 28,210
Unknown 41,230 2,107 39,123 94.9 48,818
White 957,467 36,988 920,479 96.1 991,676
ethnicity 16 groups African 1,386 315 1,071 77.3 2,065
Bangladeshi or British Bangladeshi 1,064 273 791 74.3 1,288
Caribbean 5,817 938 4,879 83.9 7,427
Chinese 1,386 98 1,288 92.9 1,736
Other 4,137 427 3,710 89.7 4,998
Other Asian 3,703 448 3,255 87.9 4,438
British or Mixed British 909,888 34,244 875,644 96.2 939,764
Indian or British Indian 13,503 1,134 12,369 91.6 14,931
Irish 8,911 476 8,435 94.7 9,471
Other Black 1,043 175 868 83.2 1,414
Other White 38,668 2,275 36,393 94.1 42,434
Other mixed 1,022 84 938 91.8 1,183
Pakistani or British Pakistani 6,090 1,841 4,249 69.8 7,546
Unknown 41,237 2,114 39,123 94.9 48,832
White + Asian 476 35 441 92.6 539
White + Black African 266 35 231 86.8 378
White + Black Caribbean 938 126 812 86.6 1,176
Index of Multiple Deprivation (quintiles) 1 Most deprived 128,065 10,164 117,901 92.1 138,446
2 170,765 9,030 161,735 94.7 181,132
3 233,646 9,296 224,350 96.0 244,244
4 243,488 8,435 235,053 96.5 253,029
5 Least deprived 244,440 7,189 237,251 97.1 252,336
Unknown 19,124 917 18,207 95.2 20,440
BMI 30+ 184,597 7,959 176,638 95.7 190,729
under 30 854,924 37,058 817,866 95.7 898,905
Housebound no 933,611 35,574 898,037 96.2 977,746
yes 105,910 9,450 96,460 91.1 111,881
Chronic cardiac disease no 722,365 30,499 691,866 95.8 761,348
yes 317,156 14,525 302,631 95.4 328,279
Current COPD no 929,565 39,529 890,036 95.7 975,821
yes 109,956 5,488 104,468 95.0 113,806
DMARDs no 1,006,299 43,701 962,598 95.7 1,055,516
yes 33,222 1,316 31,906 96.0 34,111
Dementia no 958,657 38,822 919,835 96.0 1,004,297
yes 80,871 6,202 74,669 92.3 85,330
Psychosis, schizophrenia, or bipolar no 1,032,150 44,338 987,812 95.7 1,081,584
yes 7,378 686 6,692 90.7 8,043
Learning disability no 1,039,073 44,968 994,105 95.7 1,089,137
yes 455 56 399 87.7 490
SSRI (last 12 months) no 997,780 43,092 954,688 95.7 1,046,619
yes 41,748 1,932 39,816 95.4 43,008
Chemo or radiotherapy no 1,003,044 43,652 959,392 95.6 1,052,058
yes 36,484 1,372 35,112 96.2 37,569
Cancer (lung) no 1,032,206 44,604 987,602 95.7 1,082,081
yes 7,322 420 6,902 94.3 7,546
Cancer (excluding lung/haem) no 846,426 37,884 808,542 95.5 890,638
yes 193,095 7,133 185,962 96.3 198,989
Cancer (haematological) no 1,019,753 44,282 975,471 95.7 1,069,257
yes 19,775 742 19,033 96.2 20,370
Chronic kidney disease no 716,996 30,303 686,693 95.8 755,839
yes 322,525 14,714 307,811 95.4 333,795

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 80+ Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,988,980 73,997 1,914,983 96.3 2,095,366
Sex F 1,044,701 40,684 1,004,017 96.1 1,099,777
M 944,265 33,306 910,959 96.5 995,575
Age band 70-74 1,132,026 44,135 1,087,891 96.1 1,198,162
75-79 856,940 29,855 827,085 96.5 897,197
Ethnicity (broad categories) Black 10,787 1,918 8,869 82.2 14,917
Mixed 5,460 581 4,879 89.4 6,664
Other 12,873 1,267 11,606 90.2 16,170
South Asian 49,427 6,650 42,777 86.5 57,281
Unknown 102,368 5,208 97,160 94.9 117,915
White 1,808,058 58,373 1,749,685 96.8 1,882,412
ethnicity 16 groups African 3,633 777 2,856 78.6 5,404
Bangladeshi or British Bangladeshi 1,575 399 1,176 74.7 1,918
Caribbean 5,152 805 4,347 84.4 6,832
Chinese 3,416 210 3,206 93.9 4,375
Other 9,457 1,050 8,407 88.9 11,802
Other Asian 9,863 1,078 8,785 89.1 11,697
British or Mixed British 1,719,669 53,165 1,666,504 96.9 1,782,298
Indian or British Indian 28,280 2,352 25,928 91.7 31,556
Irish 14,357 686 13,671 95.2 15,463
Other Black 2,002 329 1,673 83.6 2,681
Other White 74,011 4,515 69,496 93.9 84,623
Other mixed 2,219 231 1,988 89.6 2,625
Pakistani or British Pakistani 9,723 2,835 6,888 70.8 12,117
Unknown 102,375 5,208 97,167 94.9 117,936
White + Asian 1,232 77 1,155 93.8 1,428
White + Black African 833 133 700 84.0 1,106
White + Black Caribbean 1,176 140 1,036 88.1 1,505
Index of Multiple Deprivation (quintiles) 1 Most deprived 251,741 18,536 233,205 92.6 273,238
2 331,954 15,701 316,253 95.3 353,787
3 445,011 14,938 430,073 96.6 467,670
4 463,407 12,908 450,499 97.2 484,099
5 Least deprived 458,150 10,150 448,000 97.8 474,824
Unknown 38,703 1,757 36,946 95.5 41,748
BMI 30+ 499,205 18,928 480,277 96.2 517,650
under 30 1,489,761 55,062 1,434,699 96.3 1,577,709
Housebound no 1,950,116 69,930 1,880,186 96.4 2,053,870
yes 38,850 4,060 34,790 89.5 41,489
Chronic cardiac disease no 1,623,510 58,520 1,564,990 96.4 1,715,371
yes 365,463 15,477 349,986 95.8 379,988
Current COPD no 1,798,923 64,421 1,734,502 96.4 1,897,882
yes 190,050 9,576 180,474 95.0 197,470
DMARDs no 1,917,034 71,526 1,845,508 96.3 2,021,257
yes 71,939 2,471 69,468 96.6 74,102
Dementia no 1,947,680 70,861 1,876,819 96.4 2,051,924
yes 41,286 3,129 38,157 92.4 43,428
Psychosis, schizophrenia, or bipolar no 1,970,563 72,289 1,898,274 96.3 2,074,982
yes 18,410 1,708 16,702 90.7 20,377
Learning disability no 1,986,215 73,598 1,912,617 96.3 2,092,405
yes 2,758 399 2,359 85.5 2,954
SSRI (last 12 months) no 1,886,241 69,692 1,816,549 96.3 1,989,421
yes 102,732 4,305 98,427 95.8 105,938
Chemo or radiotherapy no 1,919,078 71,743 1,847,335 96.3 2,023,315
yes 69,895 2,254 67,641 96.8 72,044
Cancer (lung) no 1,975,946 73,297 1,902,649 96.3 2,081,884
yes 13,027 700 12,327 94.6 13,475
Cancer (excluding lung/haem) no 1,700,384 64,876 1,635,508 96.2 1,797,404
yes 288,589 9,121 279,468 96.8 297,955
Cancer (haematological) no 1,958,411 72,891 1,885,520 96.3 2,063,733
yes 30,562 1,106 29,456 96.4 31,626
Chronic kidney disease no 1,732,108 63,952 1,668,156 96.3 1,829,597
yes 256,858 10,038 246,820 96.1 265,762

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 70-79 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among care home population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 100,597 6,727 93,870 93.3 110,383
Sex F 70,700 4,403 66,297 93.8 77,112
M 29,890 2,324 27,566 92.2 33,271
Age band 65-69 5,481 560 4,921 89.8 6,244
70-74 8,764 791 7,973 91.0 9,814
75-79 12,460 952 11,508 92.4 13,867
80-84 18,060 1,169 16,891 93.5 19,852
85-89 23,933 1,512 22,421 93.7 26,173
90+ 31,885 1,729 30,156 94.6 34,426
Ethnicity (broad categories) Black 546 70 476 87.2 714
Mixed 301 35 266 88.4 343
Other 462 35 427 92.4 518
South Asian 868 91 777 89.5 1,029
Unknown 1,974 112 1,862 94.3 2,254
White 96,446 6,391 90,055 93.4 105,518
Dementia no 45,661 3,416 42,245 92.5 50,834
yes 54,936 3,311 51,625 94.0 59,549

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Third Doses Overdue Among Care Home Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 721,420 120,064 601,356 83.4 825,251
newly shielded since feb 15 no 438,627 54,117 384,510 87.7 485,758
yes 282,793 65,954 216,839 76.7 339,493
Sex F 404,369 71,743 332,626 82.3 465,360
M 317,044 48,321 268,723 84.8 359,877
Age band 16-29 50,141 15,610 34,531 68.9 66,920
30-39 99,911 27,636 72,275 72.3 126,014
40-49 142,170 29,386 112,784 79.3 165,487
50-59 206,808 28,364 178,444 86.3 229,117
60-69 222,383 19,075 203,308 91.4 237,706
Ethnicity (broad categories) Black 31,430 10,073 21,357 68.0 44,674
Mixed 10,738 2,800 7,938 73.9 14,371
Other 14,049 3,717 10,332 73.5 18,123
South Asian 90,006 27,657 62,349 69.3 108,031
Unknown 21,532 3,591 17,941 83.3 25,221
White 553,658 72,226 481,432 87.0 614,824
Index of Multiple Deprivation (quintiles) 1 Most deprived 199,633 48,139 151,494 75.9 240,912
2 160,797 29,498 131,299 81.7 185,864
3 139,944 19,173 120,771 86.3 157,024
4 112,623 12,320 100,303 89.1 123,536
5 Least deprived 89,481 7,588 81,893 91.5 96,026
Unknown 18,935 3,346 15,589 82.3 21,875
Learning disability no 697,123 116,529 580,594 83.3 798,329
yes 24,290 3,535 20,755 85.4 26,915
Chronic kidney disease no 669,298 114,079 555,219 83.0 768,348
yes 52,115 5,985 46,130 88.5 56,896

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among Shielding (Aged 16-69) Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,002,400 55,475 946,925 94.5 1,088,416
Sex F 515,585 28,756 486,829 94.4 557,207
M 486,808 26,712 460,096 94.5 531,202
Ethnicity (broad categories) Black 8,169 1,736 6,433 78.7 11,662
Mixed 4,095 567 3,528 86.2 5,215
Other 9,534 1,281 8,253 86.6 12,698
South Asian 38,675 6,762 31,913 82.5 45,745
Unknown 69,006 4,837 64,169 93.0 83,629
White 872,914 40,285 832,629 95.4 929,453
ethnicity 16 groups African 3,143 735 2,408 76.6 4,641
Bangladeshi or British Bangladeshi 1,617 406 1,211 74.9 1,890
Caribbean 3,283 686 2,597 79.1 4,690
Chinese 3,059 301 2,758 90.2 4,088
Other 6,489 987 5,502 84.8 8,617
Other Asian 7,210 924 6,286 87.2 8,666
British or Mixed British 825,937 35,546 790,391 95.7 869,911
Indian or British Indian 20,965 2,317 18,648 88.9 23,933
Irish 6,104 406 5,698 93.3 6,804
Other Black 1,743 315 1,428 81.9 2,331
Other White 40,852 4,333 36,519 89.4 52,703
Other mixed 1,603 217 1,386 86.5 2,030
Pakistani or British Pakistani 8,876 3,115 5,761 64.9 11,249
Unknown 69,027 4,837 64,190 93.0 83,657
White + Asian 917 91 826 90.1 1,071
White + Black African 679 98 581 85.6 938
White + Black Caribbean 896 154 742 82.8 1,176
Index of Multiple Deprivation (quintiles) 1 Most deprived 136,087 14,623 121,464 89.3 155,162
2 173,285 12,453 160,832 92.8 191,506
3 222,614 11,011 211,603 95.1 240,856
4 227,563 9,079 218,484 96.0 243,292
5 Least deprived 221,417 6,937 214,480 96.9 233,751
Unknown 21,427 1,365 20,062 93.6 23,842
BMI 30+ 258,349 13,874 244,475 94.6 272,818
under 30 744,051 41,601 702,450 94.4 815,591
Housebound no 997,948 54,866 943,082 94.5 1,083,376
yes 4,452 616 3,836 86.2 5,033
Chronic cardiac disease no 894,229 48,748 845,481 94.5 973,343
yes 108,171 6,727 101,444 93.8 115,066
Current COPD no 963,830 52,661 911,169 94.5 1,047,130
yes 38,563 2,807 35,756 92.7 41,279
DMARDs no 982,646 54,530 928,116 94.5 1,067,710
yes 19,754 945 18,809 95.2 20,699
Dementia no 996,870 54,999 941,871 94.5 1,082,417
yes 5,530 483 5,047 91.3 5,992
Psychosis, schizophrenia, or bipolar no 992,236 54,215 938,021 94.5 1,076,614
yes 10,157 1,260 8,897 87.6 11,795
Learning disability no 1,000,125 55,118 945,007 94.5 1,085,896
yes 2,275 357 1,918 84.3 2,513
SSRI (last 12 months) no 942,662 51,786 890,876 94.5 1,025,745
yes 59,731 3,689 56,042 93.8 62,664
Chemo or radiotherapy no 982,835 54,586 928,249 94.4 1,067,934
yes 19,558 882 18,676 95.5 20,475
Cancer (lung) no 1,000,454 55,300 945,154 94.5 1,086,337
yes 1,939 168 1,771 91.3 2,072
Cancer (excluding lung/haem) no 915,131 51,541 863,590 94.4 996,765
yes 87,262 3,927 83,335 95.5 91,644
Cancer (haematological) no 998,753 55,300 943,453 94.5 1,084,531
yes 3,647 182 3,465 95.0 3,878
Chronic kidney disease no 954,331 52,759 901,572 94.5 1,037,757
yes 48,062 2,716 45,346 94.3 50,652

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 65-69 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 69,167 15,617 53,550 77.4 85,253
Sex F 26,915 5,684 21,231 78.9 32,200
M 42,252 9,940 32,312 76.5 53,053
Age band 16-17 2,457 938 1,519 61.8 4,851
18-29 23,723 6,692 17,031 71.8 30,751
30-34 9,016 2,135 6,881 76.3 11,144
35-39 6,797 1,400 5,397 79.4 8,092
40-44 5,488 966 4,522 82.4 6,300
45-49 5,369 924 4,445 82.8 6,083
50-54 5,894 945 4,949 84.0 6,552
55-59 5,887 924 4,963 84.3 6,531
60-64 4,536 714 3,822 84.3 4,949
Ethnicity (broad categories) Black 798 322 476 59.6 1,442
Mixed 763 231 532 69.7 1,176
Other 525 168 357 68.0 777
South Asian 3,409 1,449 1,960 57.5 4,977
Unknown 4,613 1,099 3,514 76.2 5,740
White 59,059 12,348 46,711 79.1 71,134

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those who are shielding.

Third Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,177,442 100,695 1,076,747 91.4 1,307,600
Sex F 593,516 49,371 544,145 91.7 652,001
M 583,919 51,317 532,602 91.2 655,592
Ethnicity (broad categories) Black 13,930 3,843 10,087 72.4 20,692
Mixed 6,454 1,078 5,376 83.3 8,442
Other 12,747 2,289 10,458 82.0 17,507
South Asian 45,731 9,688 36,043 78.8 54,684
Unknown 95,109 9,359 85,750 90.2 118,020
White 1,003,464 74,431 929,033 92.6 1,088,241
ethnicity 16 groups African 5,523 1,652 3,871 70.1 8,029
Bangladeshi or British Bangladeshi 2,016 511 1,505 74.7 2,380
Caribbean 5,222 1,421 3,801 72.8 8,127
Chinese 3,934 455 3,479 88.4 5,236
Other 8,827 1,834 6,993 79.2 12,285
Other Asian 9,751 1,624 8,127 83.3 11,858
British or Mixed British 943,880 64,876 879,004 93.1 1,008,091
Indian or British Indian 23,779 3,570 20,209 85.0 27,503
Irish 5,985 532 5,453 91.1 6,853
Other Black 3,178 763 2,415 76.0 4,529
Other White 53,550 9,016 44,534 83.2 73,255
Other mixed 2,464 378 2,086 84.7 3,227
Pakistani or British Pakistani 10,185 3,990 6,195 60.8 12,950
Unknown 95,144 9,359 85,785 90.2 118,048
White + Asian 1,330 168 1,162 87.4 1,561
White + Black African 1,169 245 924 79.0 1,575
White + Black Caribbean 1,498 294 1,204 80.4 2,086
Index of Multiple Deprivation (quintiles) 1 Most deprived 170,212 26,565 143,647 84.4 201,796
2 208,460 22,463 185,997 89.2 236,705
3 258,160 20,195 237,965 92.2 284,886
4 262,696 16,695 246,001 93.6 285,607
5 Least deprived 252,399 12,551 239,848 95.0 269,591
Unknown 25,508 2,226 23,282 91.3 29,008
BMI 30+ 298,179 23,870 274,309 92.0 319,074
under 30 879,263 76,825 802,438 91.3 988,512
Chronic cardiac disease no 1,086,344 92,351 993,993 91.5 1,209,131
yes 91,091 8,344 82,747 90.8 98,455
Current COPD no 1,144,654 97,104 1,047,550 91.5 1,271,690
yes 32,788 3,591 29,197 89.0 35,903
DMARDs no 1,156,820 99,267 1,057,553 91.4 1,285,690
yes 20,622 1,428 19,194 93.1 21,903
Dementia no 1,173,900 100,303 1,073,597 91.5 1,303,694
yes 3,542 399 3,143 88.7 3,892
Psychosis, schizophrenia, or bipolar no 1,164,716 98,784 1,065,932 91.5 1,292,326
yes 12,726 1,918 10,808 84.9 15,260
SSRI (last 12 months) no 1,096,767 93,352 1,003,415 91.5 1,221,514
yes 80,668 7,336 73,332 90.9 86,072
Chemo or radiotherapy no 1,159,711 99,463 1,060,248 91.4 1,288,826
yes 17,724 1,232 16,492 93.0 18,760
Cancer (lung) no 1,176,154 100,527 1,075,627 91.5 1,306,172
yes 1,288 168 1,120 87.0 1,421
Cancer (excluding lung/haem) no 1,105,608 95,746 1,009,862 91.3 1,231,139
yes 71,834 4,949 66,885 93.1 76,454
Cancer (haematological) no 1,174,187 100,464 1,073,723 91.4 1,304,086
yes 3,255 238 3,017 92.7 3,507
Chronic kidney disease no 1,146,859 98,287 1,048,572 91.4 1,274,798
yes 30,576 2,401 28,175 92.1 32,788

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 60-64 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,349,404 160,993 1,188,411 88.1 1,537,634
Sex F 677,040 76,622 600,418 88.7 756,462
M 672,357 84,371 587,986 87.5 781,158
Ethnicity (broad categories) Black 21,413 6,622 14,791 69.1 32,851
Mixed 9,604 2,037 7,567 78.8 12,999
Other 16,863 3,577 13,286 78.8 23,870
South Asian 51,639 12,740 38,899 75.3 62,846
Unknown 113,841 15,435 98,406 86.4 147,077
White 1,136,030 120,589 1,015,441 89.4 1,257,970
ethnicity 16 groups African 9,254 3,045 6,209 67.1 13,713
Bangladeshi or British Bangladeshi 2,674 777 1,897 70.9 3,136
Caribbean 6,741 1,988 4,753 70.5 11,123
Chinese 5,019 742 4,277 85.2 6,797
Other 11,837 2,835 9,002 76.0 17,059
Other Asian 12,677 2,569 10,108 79.7 15,771
British or Mixed British 1,062,579 106,099 956,480 90.0 1,155,000
Indian or British Indian 25,298 4,739 20,559 81.3 29,561
Irish 6,881 833 6,048 87.9 8,155
Other Black 5,425 1,589 3,836 70.7 8,015
Other White 66,556 13,657 52,899 79.5 94,815
Other mixed 3,451 728 2,723 78.9 4,655
Pakistani or British Pakistani 11,004 4,648 6,356 57.8 14,392
Unknown 113,848 15,435 98,413 86.4 147,084
White + Asian 2,002 287 1,715 85.7 2,429
White + Black African 1,764 455 1,309 74.2 2,485
White + Black Caribbean 2,394 574 1,820 76.0 3,437
Index of Multiple Deprivation (quintiles) 1 Most deprived 202,251 40,859 161,392 79.8 249,501
2 239,876 35,434 204,442 85.2 281,267
3 292,488 32,634 259,854 88.8 330,855
4 297,542 27,440 270,102 90.8 329,910
5 Least deprived 288,337 21,301 267,036 92.6 312,732
Unknown 28,896 3,318 25,578 88.5 33,355
BMI 30+ 329,175 35,798 293,377 89.1 357,665
under 30 1,020,222 125,195 895,027 87.7 1,179,955
Chronic cardiac disease no 1,281,119 152,600 1,128,519 88.1 1,462,167
yes 68,278 8,393 59,885 87.7 75,453
Current COPD no 1,324,078 157,157 1,166,921 88.1 1,508,997
yes 25,319 3,836 21,483 84.8 28,623
DMARDs no 1,328,782 159,005 1,169,777 88.0 1,515,430
yes 20,615 1,988 18,627 90.4 22,190
Psychosis, schizophrenia, or bipolar no 1,333,885 158,165 1,175,720 88.1 1,518,272
yes 15,512 2,828 12,684 81.8 19,348
SSRI (last 12 months) no 1,247,834 149,009 1,098,825 88.1 1,428,014
yes 101,563 11,984 89,579 88.2 109,599
Chronic kidney disease no 1,329,048 158,872 1,170,176 88.0 1,515,416
yes 20,349 2,121 18,228 89.6 22,204

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 55-59 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,341,662 211,316 1,130,346 84.2 1,582,154
Sex F 676,214 98,721 577,493 85.4 772,093
M 665,441 112,595 552,846 83.1 810,047
Ethnicity (broad categories) Black 24,269 8,666 15,603 64.3 38,577
Mixed 11,375 2,842 8,533 75.0 15,967
Other 21,140 5,292 15,848 75.0 31,122
South Asian 71,687 21,182 50,505 70.5 90,293
Unknown 120,344 19,964 100,380 83.4 161,014
White 1,092,840 153,363 939,477 86.0 1,245,167
ethnicity 16 groups African 13,384 5,054 8,330 62.2 20,412
Bangladeshi or British Bangladeshi 4,431 1,435 2,996 67.6 5,236
Caribbean 5,215 1,659 3,556 68.2 9,303
Chinese 5,698 945 4,753 83.4 7,938
Other 15,442 4,354 11,088 71.8 23,184
Other Asian 17,479 4,193 13,286 76.0 22,358
British or Mixed British 1,007,027 131,950 875,077 86.9 1,116,521
Indian or British Indian 31,150 6,923 24,227 77.8 37,310
Irish 6,636 987 5,649 85.1 8,211
Other Black 5,677 1,953 3,724 65.6 8,869
Other White 79,156 20,426 58,730 74.2 120,421
Other mixed 4,144 1,029 3,115 75.2 5,929
Pakistani or British Pakistani 18,620 8,624 9,996 53.7 25,382
Unknown 120,358 19,964 100,394 83.4 161,021
White + Asian 2,506 448 2,058 82.1 3,115
White + Black African 2,359 728 1,631 69.1 3,437
White + Black Caribbean 2,373 637 1,736 73.2 3,500
Index of Multiple Deprivation (quintiles) 1 Most deprived 211,281 53,984 157,297 74.4 275,975
2 242,536 46,809 195,727 80.7 296,835
3 284,641 42,210 242,431 85.2 332,493
4 289,786 35,658 254,128 87.7 329,196
5 Least deprived 283,647 28,091 255,556 90.1 312,368
Unknown 29,757 4,550 25,207 84.7 35,273
BMI 30+ 313,684 44,660 269,024 85.8 347,760
under 30 1,027,964 166,649 861,315 83.8 1,234,380
Chronic cardiac disease no 1,297,905 204,309 1,093,596 84.3 1,532,174
yes 43,750 7,000 36,750 84.0 49,966
Current COPD no 1,325,345 208,131 1,117,214 84.3 1,563,044
yes 16,303 3,171 13,132 80.5 19,096
DMARDs no 1,323,875 209,251 1,114,624 84.2 1,562,701
yes 17,780 2,065 15,715 88.4 19,439
Psychosis, schizophrenia, or bipolar no 1,326,199 207,970 1,118,229 84.3 1,561,924
yes 15,456 3,339 12,117 78.4 20,216
SSRI (last 12 months) no 1,234,436 195,622 1,038,814 84.2 1,464,596
yes 107,212 15,687 91,525 85.4 117,544
Chronic kidney disease no 1,330,511 209,867 1,120,644 84.2 1,569,645
yes 11,137 1,442 9,695 87.1 12,495

Footnotes:

  • Patient counts rounded to the nearest 7
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 50-54 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Cumulative third dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Third Doses due at 05 Jan 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 2,255,414 593,089 1,662,325 73.7 2,991,716
Sex F 1,149,904 278,712 871,192 75.8 1,430,100
M 1,105,475 314,370 791,105 71.6 1,561,560
Ethnicity (broad categories) Black 52,024 24,143 27,881 53.6 93,149
Mixed 27,230 9,590 17,640 64.8 43,596
Other 56,126 19,866 36,260 64.6 93,737
South Asian 194,026 75,054 118,972 61.3 275,492
Unknown 187,985 52,318 135,667 72.2 295,113
White 1,737,995 412,118 1,325,877 76.3 2,190,580
ethnicity 16 groups African 34,853 16,548 18,305 52.5 59,129
Bangladeshi or British Bangladeshi 14,623 6,118 8,505 58.2 19,243
Caribbean 6,370 2,695 3,675 57.7 14,735
Chinese 14,651 3,514 11,137 76.0 23,086
Other 41,482 16,352 25,130 60.6 70,665
Other Asian 45,773 15,757 30,016 65.6 65,478
British or Mixed British 1,525,958 329,889 1,196,069 78.4 1,810,809
Indian or British Indian 84,000 25,550 58,450 69.6 114,191
Irish 10,675 2,485 8,190 76.7 14,987
Other Black 10,801 4,900 5,901 54.6 19,285
Other White 201,404 79,772 121,632 60.4 364,819
Other mixed 10,591 3,654 6,937 65.5 17,395
Pakistani or British Pakistani 49,616 27,608 22,008 44.4 76,566
Unknown 187,964 52,297 135,667 72.2 295,092
White + Asian 6,153 1,799 4,354 70.8 8,638
White + Black African 6,251 2,576 3,675 58.8 10,087
White + Black Caribbean 4,214 1,554 2,660 63.1 7,455
Index of Multiple Deprivation (quintiles) 1 Most deprived 374,416 144,508 229,908 61.4 580,524
2 415,471 128,457 287,014 69.1 585,774
3 467,460 117,614 349,846 74.8 613,711
4 469,882 102,039 367,843 78.3 584,675
5 Least deprived 465,164 84,763 380,401 81.8 546,651
Unknown 62,993 15,708 47,285 75.1 80,332
BMI 30+ 434,273 102,347 331,926 76.4 515,550
under 30 1,821,106 490,735 1,330,371 73.1 2,476,110
Chronic cardiac disease no 2,221,429 585,445 1,635,984 73.6 2,950,059
yes 33,950 7,637 26,313 77.5 41,601
Current COPD no 2,243,080 589,757 1,653,323 73.7 2,975,889
yes 12,292 3,318 8,974 73.0 15,771
DMARDs no 2,232,300 588,889 1,643,411 73.6 2,964,962
yes 23,079 4,193 18,886 81.8 26,698
Psychosis, schizophrenia, or bipolar no 2,228,562 585,795 1,642,767 73.7 2,953,839
yes 26,817 7,287 19,530 72.8 37,821
SSRI (last 12 months) no 2,094,463 555,856 1,538,607 73.5 2,803,052
yes 160,916 37,226 123,690 76.9 188,608
Chronic kidney disease no 2,245,901 591,241 1,654,660 73.7 2,980,474
yes 9,478 1,841 7,637 80.6 11,186

Footnotes:

  • Patient counts rounded to the nearest 7
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Third Doses Overdue Among 40-49 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Summary

Third Doses due at 05 Jan 2022 (n) Third doses given (% of due) Third doses given (n) Third doses overdue (n) Total population
80+ 1,039,528 95.7 994,504 45,024 1,089,634
70-79 1,988,980 96.3 1,914,983 73,997 2,095,366
care home 100,597 93.3 93,870 6,727 110,383
shielding (aged 16-69) 721,420 83.4 601,356 120,064 825,251
65-69 1,002,400 94.5 946,925 55,475 1,088,416
LD (aged 16-64) 69,167 77.4 53,550 15,617 85,253
60-64 1,177,442 91.4 1,076,747 100,695 1,307,600
55-59 1,349,404 88.1 1,188,411 160,993 1,537,634
50-54 1,341,662 84.2 1,130,346 211,316 1,582,154
40-49 2,255,414 73.7 1,662,325 593,089 2,991,716